Vacc-Flu

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVacc-Flu
Drug Alias Nameinfluenza vaccine (Bionor Immuno/Norweign Institute of Public Health/St Georges Hospital Medical School)influenza vaccine (Bionor Immuno)universal influenza vaccine (Bionor Pharma ASA/Norweign Institute of Public Health/St Georges Hospital Medical School)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorwayUnited Kingdom
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesBionor Holding As
China Registration ClassN/A

Develop Information

Active CompaniesBionor Holding As
Inactive CompaniesNorwegian Institute Of Public HealthSt Georges University of London
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A